These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 10323782

  • 1. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
    Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, Berliner JA.
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782
    [Abstract] [Full Text] [Related]

  • 2. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.
    Ivandic B, Castellani LW, Wang XP, Qiao JH, Mehrabian M, Navab M, Fogelman AM, Grass DS, Swanson ME, de Beer MC, de Beer F, Lusis AJ.
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1284-90. PubMed ID: 10323781
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M.
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [Abstract] [Full Text] [Related]

  • 4. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
    Wooton-Kee CR, Boyanovsky BB, Nasser MS, de Villiers WJ, Webb NR.
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):762-7. PubMed ID: 14962950
    [Abstract] [Full Text] [Related]

  • 5. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
    Tietge UJ, Maugeais C, Lund-Katz S, Grass D, deBeer FC, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2002 Jul 01; 22(7):1213-8. PubMed ID: 12117740
    [Abstract] [Full Text] [Related]

  • 6. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.
    Watson AD, Leitinger N, Navab M, Faull KF, Hörkkö S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA.
    J Biol Chem; 1997 May 23; 272(21):13597-607. PubMed ID: 9153208
    [Abstract] [Full Text] [Related]

  • 7. Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice.
    Webb NR, Bostrom MA, Szilvassy SJ, van der Westhuyzen DR, Daugherty A, de Beer FC.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):263-8. PubMed ID: 12588769
    [Abstract] [Full Text] [Related]

  • 8. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.
    Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA.
    Arterioscler Thromb Vasc Biol; 2000 Oct 01; 20(10):2248-54. PubMed ID: 11031211
    [Abstract] [Full Text] [Related]

  • 9. Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA.
    Eckey R, Menschikowski M, Lattke P, Jaross W.
    Inflammation; 2004 Apr 01; 28(2):59-65. PubMed ID: 15379211
    [Abstract] [Full Text] [Related]

  • 10. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
    Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM.
    J Lipid Res; 2000 Sep 01; 41(9):1495-508. PubMed ID: 10974057
    [Abstract] [Full Text] [Related]

  • 11. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress.
    Tietge UJ, Pratico D, Ding T, Funk CD, Hildebrand RB, Van Berkel T, Van Eck M.
    J Lipid Res; 2005 Aug 01; 46(8):1604-14. PubMed ID: 15897607
    [Abstract] [Full Text] [Related]

  • 12. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.
    Shih DM, Gu L, Hama S, Xia YR, Navab M, Fogelman AM, Lusis AJ.
    J Clin Invest; 1996 Apr 01; 97(7):1630-9. PubMed ID: 8601628
    [Abstract] [Full Text] [Related]

  • 13. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
    Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, Brennan ML, Lusis AJ, Fogelman AM, La Du BN.
    J Clin Invest; 1997 Apr 15; 99(8):2005-19. PubMed ID: 9109446
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M, Bandlow N, Tietge UJ, Grote K, Pfeilschifter J, Kaszkin M, Beck S, Drexler H, Schieffer B.
    Atherosclerosis; 2007 Sep 15; 194(1):62-70. PubMed ID: 17069818
    [Abstract] [Full Text] [Related]

  • 15. New phospholipase A(2) isozymes with a potential role in atherosclerosis.
    Murakami M, Kudo I.
    Curr Opin Lipidol; 2003 Oct 15; 14(5):431-6. PubMed ID: 14501581
    [Abstract] [Full Text] [Related]

  • 16. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice.
    Forte TM, Subbanagounder G, Berliner JA, Blanche PJ, Clermont AO, Jia Z, Oda MN, Krauss RM, Bielicki JK.
    J Lipid Res; 2002 Mar 15; 43(3):477-85. PubMed ID: 11893784
    [Abstract] [Full Text] [Related]

  • 17. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice.
    Bostrom MA, Boyanovsky BB, Jordan CT, Wadsworth MP, Taatjes DJ, de Beer FC, Webb NR.
    Arterioscler Thromb Vasc Biol; 2007 Mar 15; 27(3):600-6. PubMed ID: 17204667
    [Abstract] [Full Text] [Related]

  • 18. Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine.
    Ahmed Z, Babaei S, Maguire GF, Draganov D, Kuksis A, La Du BN, Connelly PW.
    Cardiovasc Res; 2003 Jan 15; 57(1):225-31. PubMed ID: 12504832
    [Abstract] [Full Text] [Related]

  • 19. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein.
    Watson AD, Subbanagounder G, Welsbie DS, Faull KF, Navab M, Jung ME, Fogelman AM, Berliner JA.
    J Biol Chem; 1999 Aug 27; 274(35):24787-98. PubMed ID: 10455151
    [Abstract] [Full Text] [Related]

  • 20. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H.
    J Biol Chem; 2002 Aug 09; 277(32):29116-24. PubMed ID: 12021277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.